B. S. Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 04-07-2024
- Paid Up Capital ₹ 0.11 M
as on 04-07-2024
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.50 M
as on 04-07-2024
- Revenue -24.06%
(FY 2023)
- Profit -9.42%
(FY 2023)
- Ebitda 68.47%
(FY 2023)
- Net Worth 29.31%
(FY 2023)
- Total Assets 5.86%
(FY 2023)
About B. S. Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.11 M.
The company has closed loans amounting to ₹2.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Probir Das, Jayasri Das, and Sagnik Das serve as directors at the Company.
- CIN/LLPIN
U85190WB2007PTC118476
- Company No.
118476
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at B. S. Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Probir Das  | Managing Director | 11-Sep-2007 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jayasri Das | Director | 01-Nov-2011 | Current |
| Sagnik Das | Director | 24-Mar-2021 | Current |
Financial Performance of B. S. Biotech.
B. S. Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.06% decrease. The company also saw a slight decrease in profitability, with a 9.42% decrease in profit. The company's net worth Soared by an impressive increase of 29.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B. S. Biotech?
In 2023, B. S. Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Osaro Exim Private LimitedActive 24 years 3 months
Probir Das, Jayasri Das and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 25 Sep 2018 | ₹2.50 M | Satisfied |
How Many Employees Work at B. S. Biotech?
Unlock and access historical data on people associated with B. S. Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B. S. Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B. S. Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
